ABL1-mediated tyrosine phosphorylation of SYCP2 contributes to transcription-coupled homologous recombination and platinum resistance in ovarian cancer.

Saved in:
Bibliographic Details
Title: ABL1-mediated tyrosine phosphorylation of SYCP2 contributes to transcription-coupled homologous recombination and platinum resistance in ovarian cancer.
Authors: Gao B; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Wang X; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Long M; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Zhang F; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Wang Y; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Kumar R; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States., Veillard I; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States., Rueda BR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, United States.; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States., Yeku O; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States., Lan L; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States.
Source: NAR cancer [NAR Cancer] 2025 Sep 03; Vol. 7 (3), pp. zcaf031. Date of Electronic Publication: 2025 Sep 03 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101769553 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8674 (Electronic) Linking ISSN: 26328674 NLM ISO Abbreviation: NAR Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40918650
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ABL1-mediated tyrosine phosphorylation of SYCP2 contributes to transcription-coupled homologous recombination and platinum resistance in ovarian cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gao+B%22">Gao B</searchLink>; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States.<br /><searchLink fieldCode="AU" term="%22Long+M%22">Long M</searchLink>; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States.<br /><searchLink fieldCode="AU" term="%22Zhang+F%22">Zhang F</searchLink>; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States.<br /><searchLink fieldCode="AU" term="%22Kumar+R%22">Kumar R</searchLink>; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Veillard+I%22">Veillard I</searchLink>; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Rueda+BR%22">Rueda BR</searchLink>; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, United States.; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Yeku+O%22">Yeku O</searchLink>; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Lan+L%22">Lan L</searchLink>; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101769553%22">NAR cancer</searchLink> [NAR Cancer] 2025 Sep 03; Vol. 7 (3), pp. zcaf031. <i>Date of Electronic Publication: </i>2025 Sep 03 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101769553 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-8674 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226328674%22">26328674 </searchLink><i>NLM ISO Abbreviation: </i>NAR Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40918650
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/narcan/zcaf031
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: zcaf031
    Titles:
      – TitleFull: ABL1-mediated tyrosine phosphorylation of SYCP2 contributes to transcription-coupled homologous recombination and platinum resistance in ovarian cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gao B
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Long M
      – PersonEntity:
          Name:
            NameFull: Zhang F
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Kumar R
      – PersonEntity:
          Name:
            NameFull: Veillard I
      – PersonEntity:
          Name:
            NameFull: Rueda BR
      – PersonEntity:
          Name:
            NameFull: Yeku O
      – PersonEntity:
          Name:
            NameFull: Lan L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 09
              Text: 2025 Sep 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2632-8674
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: NAR cancer
              Type: main
ResultId 1